Global /China /Healthcare /Drug Manufacturers - General /600538
chevron_leftBack
Beihai Gofar Chuanshan Biological Co., Ltd. logo

Beihai Gofar Chuanshan Biological Co., Ltd.

600538
SSE: 600538 Delayed
6.72CNY -1.9%
0.9930 USD
As of 15 June 2026, Beihai Gofar Chuanshan Biological Co., Ltd. has a market cap of $520.53M USD, ranking #14856 globally and #4621 in China. It ranks #1323 in the Healthcare sector, and #488 in the Drug Manufacturers - General industry.
Global Rank
14856
Country Rank
4621
Sector Rank
1323
Industry Rank
488
Key Stats
Market Cap
$520.53MUSD
3.52B CNY
Enterprise Value
$508.43MUSD
3.44B CNY
Revenue (TTM)
$48.5MUSD
328.24M CNY
EBITDA (TTM)
-$2.34MUSD
-15.83M CNY
Net Income (TTM)
-$12.95MUSD
-87.62M CNY
EBITDA Margin
-4.8%
Profit Margin
-27%
PS Ratio
10.7
PB Ratio
5.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Bin Pan Li open_in_new
Employees
453
Founded
1993
Website
gofar.com.cn open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1.9% -2.2% 1.8% -5.8% 22% 29%

News

Loading...

Markets

Exchange Ticker Price
Shanghai Stock Exchange
MIC: XSHG
PRIMARY
600538
北海国发川山生物股份有限公司 Class A
ISIN: CNE000001DD2
Shares Out.:
524.198M1 Shares Float: 318.76M2
TV:
SA:
YF:
GF:
BA:
MS:
6.72 CNY
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Beihai Gofar Chuanshan Biological Co., Ltd.

Beihai Gofar Chuanshan Biological Co., Ltd., together with its subsidiaries, engages in the distribution of pharmaceutical products in China. It operates through Pharmaceutical Distribution [Industry]; Pharmaceutical Manufacturing; DNA Testing Equipment, Consumables and Testing Services; and Others segments. The company wholesales and retails various medicines and medical devices through directly operated and franchised chain drugstores. It also provides pearl eye drops, pearl powder, and pearl layer powder under the Haibao brand; weichangning granules under the Guofa brand; ethanol disinfectant; honeysuckle mixture; feier syrup; medicinal wine for traumatic injury under the Hippocampus brand; and sea snake medicinal wine. In addition, the company offers forensic DNA testing equipment, reagents, and consumables; and technical services, including DNA testing services. Further, it engages in culture and arts activities. The company was formerly known as Beihai Gofar Marine Biological Industry Co., Ltd. and changed its name to Beihai Gofar Chuanshan Biological Co., Ltd. in June 2021. Beihai Gofar Chuanshan Biological Co., Ltd. was incorporated in 1993 and is headquartered in Beihai, China.

Similar Companies

Industry: Drug Manufacturers - General (China)
Name
Market Cap diff.
PE
$53.92B
364.89B CNY
10K%
44.9
603259
$49.7B
336.36B CNY
9K%
17.2
$28.52B
223.48B HKD
5K%
35.7
$18.8B
147.32B HKD
4K%
162.3
$16.53B
111.89B CNY
3K%
-
9926
$16.01B
125.46B HKD
3K%
-
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
146K%
38.1
JNJ
$547.28B
105K%
26.4
ABBV
$360.63B
69K%
97.4
$321.52B
256.25B CHF
62K%
19.9
AZN
$288.84B
215.59B GBP
55K%
27.6
NOVN
$274.65B
218.9B CHF
53K%
20.5
chevron_leftBack